Cargando…

Safety, tolerability, and outcomes of losartan use in patients hospitalized with SARS-CoV-2 infection: A feasibility study

BACKGROUND: Retrospective studies on the use of Renin-Angiotensin-Aldosterone System blockade in patients with Coronavirus Disease 2019 (COVID-19) have been informative but conflicting, and prospective studies are required to demonstrate the safety, tolerability, and outcomes of initiating these age...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolotova, Olena, Yoo, Jeanwoo, Chaudhri, Imran, Marcos, Luis A., Sahib, Haseena, Koraishy, Farrukh M., Skopicki, Hal, Ahmad, Sahar, Mallipattu, Sandeep K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773257/ https://www.ncbi.nlm.nih.gov/pubmed/33378401 http://dx.doi.org/10.1371/journal.pone.0244708

Ejemplares similares

Dialysis resource allocation in critical care: the impact of the COVID-19 pandemic and the promise of big data analytics
por: Koraishy, Farrukh M., et al.
Publicado: (2023)

Association of Serum Ferritin Levels and Methylprednisolone Treatment With Outcomes in Nonintubated Patients With Severe COVID-19 Pneumonia
por: Papamanoli, Aikaterini, et al.
Publicado: (2021)

Admission NT‐proBNP and outcomes in patients without history of heart failure hospitalized with COVID‐19
por: Yoo, Jeanwoo, et al.
Publicado: (2021)

N-Terminal Pro-B-Type Natriuretic Peptide and Mortality in Patients without Heart Failure Hospitalized with Severe Covid-19 Pneumonia
por: Yoo, Jeanwoo, et al.
Publicado: (2020)

Monitoring Hospitalized Dialysis Patients With COVID-19: Repurposing Baby Monitors for Patient and Staff Safety
por: Khan, Sobia, et al.
Publicado: (2020)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

A case of severe nephrotoxicity associated with long-term dietary supplement use
por: Koraishy, Farrukh M., et al.
Publicado: (2017)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Managing blood pressure control in Asian patients: safety and efficacy of losartan
por: Cheung, Tommy Tsang, et al.
Publicado: (2014)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

56. Long-Term Cardiovascular Outcomes After Drug-Related vs Non-Drug-Related Infective Endocarditis
por: Muncan, Brandon, et al.
Publicado: (2021)

Initial mean arterial blood pressure (MABP) measurement is a risk factor for mortality in hypertensive COVID-19 positive hospitalized patients
por: Yangchen, Tenzin, et al.
Publicado: (2023)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease
por: Kravets, Igor, et al.
Publicado: (2020)

Heart Failure: An Exploration of Recent Advances in Research and Treatment (A)
por: Szema, Anthony, et al.
Publicado: (2015)

55. Infective Endocarditis After Surgical or Transcatheter Aortic Valve Replacement
por: Papamanoli, Aikaterini, et al.
Publicado: (2021)

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
por: Ripley, Elizabeth, et al.
Publicado: (2010)

Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib
por: Fu, Ying, et al.
Publicado: (2022)

Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study
por: Kalikar, Mrunalini, et al.
Publicado: (2017)

Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety
por: Derington, Catherine G., et al.
Publicado: (2020)

An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19
por: Bengtson, Charles D., et al.
Publicado: (2021)

Meta-analysis of the effectiveness and safety of Shenyankangfu tablets combined with losartan potassium in the treatment of chronic glomerulonephritis
por: Feng, Pan-Feng, et al.
Publicado: (2022)

Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study
por: Choi, YoonJung, et al.
Publicado: (2016)

The Beneficial Role of Retinoids in Glomerular Disease
por: Mallipattu, Sandeep K., et al.
Publicado: (2015)

KLF 6: a mitochondrial regulator in the kidney
por: Mallipattu, Sandeep K., et al.
Publicado: (2015)

Feasibility, safety and tolerability of accelerated dobutamine stress echocardiography
por: Minardi, Giovanni, et al.
Publicado: (2007)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

A case of losartan-induced severe hyponatremia
por: Das, Saibal, et al.
Publicado: (2015)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Drug-Induced Liver Injury Due To Losartan
por: Diogo, Joana, et al.
Publicado: (2021)

Losartan Interactions with 2-Hydroxypropyl-β-CD
por: Palli, Vasiliki, et al.
Publicado: (2022)

A Case Report of Losartan Induced Angioedema
por: Vedantam, Venkata, et al.
Publicado: (2023)

Anti-Epileptogenesis: Some Roads Lead to Losartan
por: Sarkis, Rani A.
Publicado: (2023)

Losartan-Induced Angioedema: A Case Report
por: Mann, Henry, et al.
Publicado: (2023)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers
por: Yoon, Deok Yong, et al.
Publicado: (2020)

IR microspectroscopic investigation of the interaction of some losartan salts with human stratum corneum protein and its effect on losartan transdermal permeation
por: Mansour, Randa S. H., et al.
Publicado: (2023)

Simultaneous determination of losartan, losartan acid and amlodipine in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
por: Karra, Vijaya Kumari, et al.
Publicado: (2012)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke
por: Kjeldsen, Sverre E, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_flvg3d82o131v3h3lcg0or2480